Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from GENinCode UK Ltd. ( (GB:GENI) ) is now available.
GENinCode UK Ltd. has successfully raised approximately £4.1 million through a fundraising effort comprising a Placing, Subscription, and Retail Offer, issuing over 109 million new shares. This capital raise, conditional upon a general meeting and admission to trading on AIM, is expected to strengthen the company’s financial position and support its focus on cardiovascular and ovarian cancer diagnostics.
More about GENinCode UK Ltd.
GENinCode UK Ltd. is a genetics company specializing in the prevention of cardiovascular disease and the early detection of ovarian cancer.
YTD Price Performance: -2.63%
Average Trading Volume: 616,176
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £6.55M
For a thorough assessment of GENI stock, go to TipRanks’ Stock Analysis page.